Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Venneos

Venneos
2014 FOUNDED
OOB STATUS
1-10 EMPLOYEES
Out of Business LATEST DEAL TYPE
Description

Developer of a silicon-chip-based imaging system designed to analyse biological cells. The company's imaging system helps in the label-free analysis of biological cells and to detect cellular changes which remain invisible with other technologies, enabling researchers to acquire information in areas such as tumor biology, immunology and pharmacology as well as in pharma and biotech companies.

Website
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Primary Office
  • Nobelstra├če 15
  • 70569 Stuttgart
  • Germany

+49 0711 0000000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Venneos’s full profile, request a free trial.

Venneos Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 01-May-2018 00.000 Completed Out of Business
3. Early Stage VC (Series A) 26-Sep-2017 00.000 Completed Generating Revenue
2. Seed Round 11-Sep-2015 $1.12M $1.12M Completed Startup
1. Grant 13-Jul-2015 $2.2K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Venneos Executive Team (4)

Name Title Board
Seat
Contact
Info
David Wehner Co-Founder & Managing Director
Ralf Zeitler Co-Founder & Managing Director
Jonas Lehmann Co-Founder
Tu Hoang Ph.D Co-Founder